Patent details

Basic Information

Publication number:

EP3181134

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP171556541

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

BIFIDOBACTERIA FOR TREATING DIABETES AND RELATED CONDITIONS

French Title of Invention:

BIFIDOBACTÉRIES POUR LE TRAITEMENT DU DIABÈTE ET DES ÉTATS APPARENTÉS

German Title of Invention:

BIFIDOBAKTERIEN ZUR BEHANDLUNG VON DIABETES UND ASSOZIIERTEN ERKRANKUNGEN

SPC Number:

Dates

Filing date:

18/06/2010

Grant date:

30/10/2019

EP Publication Date:

21/06/2017

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

30/10/2019

EP B1 Publication Date:

30/10/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

18/06/2020

Expiration date:

18/06/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

23/10/2019

 

 

Name:

DuPont Nutrition Biosciences ApS

Address:

Langebrogade 1, 1411 Copenhagen K, Denmark (DK)

Inventor

1

Name:

BURCELIN, Rémy

Address:

France (FR)

2

Name:

LAHTINEN, Sampo

Address:

Finland (FI)

3

Name:

CARCANO, Didier

Address:

France (FR)

Priority

Priority Number:

218563 P

Priority Date:

19/06/2009

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/155; A61K 31/715; A61P 3/04; A61P 5/50; A61K 35/745; A61K 35/747; A23L 33/135;

Publication

European Patent Bulletin

Issue number:

201944

Publication date:

30/10/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages